Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

Items Tagged ‘prostate cancer’

December 4, 2018

Research News Roundup — November 2018

By Elizabeth Zimmermann elizabethzimmermann

The Mayo Clinic Research News Roundup includes brief summaries and links to research news releases from the past month. It also connects readers to related resources. Read on for more information from Mayo Clinic Research. How viruses hijack part of your immune system and use it against you An enzyme intended to prevent autoimmune disease can be […]

View full entry

Tags: augmented human intelligence, basic science, Bradley Erickson, brain tumor, cancer, Geoffrey Johnson, Mayo Clinic Alix School of Medicine, Mayo Clinic Nicotine Dependence Center, Mayo Clinic School of Medicine, neurology, prostate cancer, radiology


August 8, 2018

New pathway in prostate cancer cells suggests possible therapy

By Sara Tiner saratiner

Expanding on previous findings, a group of Mayo researchers continue using discovery research in cells to find options for treating cancers. In their most recent paper, published in Molecular Cell, the team’s research suggest that a drug used for breast cancer may be helpful in some types of prostate cancers. “In the current study we […]

View full entry

Tags: basic science, biomedical research, gene mutation, Haojie Huang, Mayo Clinic Cancer Center, prostate cancer


October 4, 2016

Prostate biopsies down, complications up

By Elizabeth Zimmermann elizabethzimmermann

Researchers are seeking ways to make prostate cancer biopsies safer. While absolute rates of biopsy and post-biopsy complications have decreased after several benchmark prostate-specific antigen (PSA) screening publications, the relative risk for each patient continues to increase, according to a new study by Mayo Clinic researchers. The study is the largest to examine the impact […]

View full entry

Tags: Center for the Science of Health Care Delivery, Mayo Clinic Cancer Center, OptumLabs, prostate cancer


March 31, 2016

Although Prostate-specific Antigen Screenings Now Result in Fewer Biopsies, Relative Risk of Complications has Increased

By Elizabeth Zimmermann elizabethzimmermann

While absolute rates of biopsy and post-biopsy complications have decreased following several benchmark prostate-specific antigen (PSA) screening publications, the relative risk for each patient continues to increase, according to a new study by Mayo Clinic researchers. The study is the largest to examine the impact of PSA screening trials and revised PSA screening guidelines on rates […]

View full entry

Tags: Center for the Science of Health Care Delivery, Choosing Wisely, OptumLabs, prostate cancer


December 18, 2013

Luring Cancer: Custom “Bait” Catches Recurrent Prostate Cancer

By

From Mayo Clinic’s Discovery’s Edge magazine Many prostate cancer survivors live in fear of being told that their cancer has returned. It’s even scarier to be told that the doctor knows the cancer is there because of rising PSA levels, but that he can’t find it. Doctors and patients alike know that early detection of the recurrent […]

View full entry

Tags: Mayo Clinic Cancer Center, prostate cancer


November 6, 2013

Mayo Clinic's Genomic Study on Prostate Cancer

By

Certain types of “hard to treat” prostate cancer present an unanswerable challenge for physicians. That’s a nicely worded sentence for very bad news for the patient. After hormone treatment yields no response, the patient usually has two years or less to live. Surgery isn’t possible because the tumor cannot be shrunk. The reality of the […]

View full entry

Tags: Center for Individualized Medicine, Mayo Clinic Cancer Center, prostate cancer


March 25, 2013

Mayo Team Featured in Developmental Cell

By

Mark McNiven, Ph.D., is senior author on a Mayo study highlighted in the journal Developmental Cell. First author is Gina Razidlo, Ph.D., research fellow in gastroenterology. The paper, Dynamin 2 Potentiates Invasive Migration of Pancreatic Tumor Cells through Stabilization of the Rac1 GEF Vav1, is the first in an array of images on the journal’s website […]

View full entry

Tags: prostate cancer


Contact Us · Privacy Policy